
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Working out at the airport? Some fliers can already smell the sweat. - 2
Your big brain makes you human – count your neurons when you count your blessings - 3
Idris Elba is the king of the stress-watch - 4
Revvity says it will exceed 2025 profit forecast range - 5
The Development of Shipping: Controlling Towards a More Associated Future
Careful Nurturing: Techniques for Bringing up Tough Children
The Response to Self-improvement: Embracing a Development Outlook
Audits of the Top Science fiction Movies This Year
Geminid meteor shower 2025 peaks next week. Here's what you need to know about this year's best meteor shower
Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
Former biotech CEO sued over COVID vaccine alleged insider trading
Figure out What Shift Differentials Mean for Your General Attendant Compensation
7 Logically Demonstrated Techniques for Better Rest
Figure out how to Put resources into Lab Precious stones: A Novice's Aide













